Budget Daily Health Base

B87· Mostly solid

Public • 28 Jan 2026

Maximizes health impact per dollar.

← Back Try alternative layout

Buy stack

Budget Daily Health Base

budget daily high-roi

Vitamin D3

Daily

HIGH

50mg

Magnesium Glycinate

Evening

MODERATE

400mg

No interactions detected · 1 synergy found

Each dose includes evidence rationale · doses personalized to your weight

Stack note

Private note on this stack

Track how this stack felt, what you want to change next cycle, or anything you want to save privately in your member zone.

AI risk assessment

Context: No wearable data

PROAI risk assessment is available with Pro.

See plans

Stack pre-check

No personal data connected — connect wearables or upload bloodwork for a personalised check

Clean

Supplements

Training load

Unknown

No flags

No duplication, stimulant, interaction, or recovery concerns detected.

Pre-check is rule-based, not medical advice. Consult a healthcare professional for personalised guidance.

Interaction Analysis

Pharmacokinetic + pair-level checks

1 synergyNo conflicts

Synergies detected

Synergy

Magnesium + Vitamin D3: activation synergyPMID:29480918

Magnesium is required for every enzymatic step that converts inactive vitamin D to its active form (calcitriol). Without adequate magnesium, high-dose D3 supplementation is inefficient. Up to 50% of people are magnesium-insufficient.

→Ensure magnesium intake (300–400mg) when supplementing D3 > 2000 IU.

Timing optimizations

Vitamin D3

With largest fat-containing meal

Fat-soluble. Co-ingestion with dietary fat increases absorption by 32–56%. (Onset: ~12h, half-life: ~360h)

Magnesium Glycinate

Evening (glycinate/threonate) or before bed

Magnesium promotes GABA activity and lowers core body temperature, aiding sleep onset and quality. (Onset: ~2h, half-life: ~8h)

Interaction analysis is based on peer-reviewed pharmacology. PMID links go to PubMed. Not medical advice.

Supplements

2 items

Vitamin D3Moderate

Daily • Cholecalciferol •

High ROI micronutrient for most adults.

Buy ingredient →

50mg

Prevention of acute respiratory tract infections

Moderate

Population: Children and adults (ages 0–95); 25 RCTs, n=11,321

Study type: Systematic review and meta-analysis of individual participant data from RCTs

Dose context: —

Vitamin D supplementation reduced risk of acute respiratory tract infection (adjusted OR 0.88, 95% CI 0.81–0.96); greatest benefit in those with baseline deficiency (<25 nmol/L) & those receiving daily or weekly dosing rather than bolus doses.

Citation: Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.•DOI: 10.1136/bmj.i6583•https://pubmed.ncbi.nlm.nih.gov/28202713/

IPD meta-analysis; high statistical power; effect strongest in vitamin D-deficient individuals.

Vitamin D status & physical performance in athletes

Low

Population: Competitive and recreational athletes

Study type: Narrative review

Dose context: —

Vitamin D insufficiency is prevalent among athletes, particularly indoor athletes & those in northern latitudes in winter. Insufficiency is associated with reduced muscle strength, power, & endurance; supplementation of 2,000–6,000 IU/day recommended to maintain 25(OH)D >40 ng/mL.

Citation: Yoon S, Kwon O, Kim J. Vitamin D in athletes: focus on physical performance and musculoskeletal injuries. Phys Act Nutr. 2021;25(2):20-25.•DOI: 10.20463/pan.2021.0011•https://pubmed.ncbi.nlm.nih.gov/34315203/

Narrative review; prevalence data robust, intervention evidence more limited.

Fracture prevention in elderly adults

Moderate

Population: Ambulatory and institutionalized elderly persons

Study type: Systematic review and meta-analysis of RCTs

Dose context: —

Vitamin D at 700–800 IU/day reduced hip fracture risk by 26% (RR 0.74) & any nonvertebral fracture by 23% (RR 0.77); no significant benefit was observed at 400 IU/day.

Citation: Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18):2257-64.•DOI: 10.1001/jama.293.18.2257•https://pubmed.ncbi.nlm.nih.gov/15886381/

Dose-dependent effect; 400 IU/day insufficient for fracture prevention.

Magnesium GlycinateModerate

Evening • Glycinate •

Commonly under-consumed mineral.

Buy ingredient →

400mg

Trade-offs & context

Tolerance

Loose stools at higher doses; glycinate form is better tolerated than citrate or oxide

Context: doses >400mg elemental

Timing

Drowsiness — take in the evening to leverage rather than fight this effect

Sleep quality in adults with poor sleep (magnesium bisglycinate RCT)

Moderate

Population: Adults aged 18–65 with self-reported poor sleep (n=155)

Study type: RCT (double-blind, placebo-controlled)

Dose context: 250 mg typical (range: 200–250 mg) • Duration: 8 weeks

250 mg elemental magnesium as bisglycinate modestly but significantly reduced Insomnia Severity Index score vs. placebo (−3.9 vs −2.3, p=0.049) by week 4; well-tolerated with minimal GI effects.

Citation: Abboud M et al. Nutrients. 2025.•https://pubmed.ncbi.nlm.nih.gov/40918053/

First RCT specifically using magnesium bisglycinate for sleep in a general adult population.

Insomnia in older adults (sleep latency, total sleep time)

Low

Population: Older adults with insomnia (3 RCTs, n=151)

Study type: Systematic review & meta-analysis

Dose context: 320 mg typical (range: 100–500 mg) • Duration: 8 weeks

Magnesium supplementation reduced sleep onset latency by ~17 min vs. placebo; increased sleep time & efficiency. Evidence rated low-to-very-low quality; all trials at moderate-to-high bias risk.

Citation: Mah J & Pitre T. BMC Complement Med Ther. 2021;21(1):125.•DOI: 10.1186/s12906-021-03297-z•https://pubmed.ncbi.nlm.nih.gov/33865376/

Benefit most plausible in those with low baseline magnesium. Dose refers to elemental magnesium.